Nootropics
PQQ
Pyrroloquinoline quinone has preliminary human cognitive-test findings, not established anti-aging or training benefits.
Small, short cognitive trials
Also known as: pyrroloquinoline quinone
Practical use
Reviewed practical notes
- Choose a relevant outcome
- A cognition paper cannot substantiate a muscle-recovery promise.
- Check the product and population
- Results belong to the studied preparation and participants, not every product using the same ingredient name.
- Look beyond positive subtests
- Consider the whole test battery, attrition and follow-up before judging the size of the benefit.
Overview
PQQ supplements are often discussed through mitochondrial biology. The human trials cited here measured cognitive tests over weeks. They did not measure lifespan, dementia prevention, muscle growth or athletic recovery.
Risks and limitations
One small trial reported no adverse events during its follow-up. That is limited reassurance about the studied product and duration, not a reliable estimate of uncommon harms or safety over years.
How to read this
When evaluating a PQQ claim, ask for the exact human outcome rather than a cellular mechanism. A statistically favorable test score still needs replication and evidence that the difference improves everyday functioning.
Research explained
Twelve-week cognitive testing in older adults
Who was studied
64 healthy Japanese adults aged 40 to under 80 randomized to PQQ or placebo; 58 completed the trial.
What was found
The investigators reported improvements in several computerized cognitive domains and additional cognitive assessments. No adverse events were observed in this study.
What it cannot establish
The sample was small, testing included multiple outcomes, and follow-up lasted only 12 weeks. This does not establish prevention of cognitive disease.
Read the original studyMemory outcomes across adult age groups
Who was studied
Randomized, double-blind placebo trial in healthy adults aged 20–65, followed for 12 weeks.
What was found
Composite and verbal-memory findings favored PQQ; reported effects differed across age groups and assessment times.
What it cannot establish
The abstract does not provide the sample size. Age-subgroup findings and several testing occasions need cautious interpretation; durable real-world benefit remains uncertain.
Read the original studyMitochondrial language needs a human endpoint
An energy-related mechanism can explain why researchers ask a question. It cannot answer whether a supplement improves exercise capacity or reduces fatigue. Neither cited trial tested a resistance-training or endurance outcome.
Supporting sourceSources
Sources checked 2026-10-01.
General education; not a personal treatment plan.